Investment banking to pharma corp dev?

Hi all, I'm going into an MBA program and was wondering what the path would look like if I were to want to do investment banking for a few years before recruiting for corp dev roles in pharma companies like Eli Lilly or Merck? It seems like the PE recruiting route is far more common for investment bankers... is there any corporate development recruiting or are these fully networking based opportunities?

5 Comments
 

Bump - Incoming Biopharma IB Analyst very interested in taking this path

 
Most Helpful

Banking to pharma corp dev is a solid move if you're in a healthcare coverage group. The financial modeling and deal execution skills transfer well, but you'll need to show genuine interest in the science and industry dynamics.
A few things that help make the transition:
Your deal experience matters most. If you've worked on healthcare M&A or pharma financing deals, that's your story. If not, you'll need to explain why you're pivoting and show you understand the space.
Pharma values people who can evaluate science and commercial potential, not just run DCFs. If you're coming from pure finance, expect to spend time learning therapeutic areas, regulatory pathways, and pipeline risk.
Timing wise, 2 to 3 years in banking is enough to make the move. Longer than that and you risk being seen as too finance focused. Target larger pharma with active BD teams or biotech hubs where deal flow is consistent.
I work with people making this transition. If you want to discuss positioning yourself for these roles, feel free to DM.

https://pharmacoach.carrd.co/
 

Hi, undergrad here

How useful would a Life Sciences degree be for healthcare/life sciences/biopharma IB? Someone can learn the industry without spending too much effort, but learning the raw science, as I see it, can be sort of an unfuckable quality. Is my view flawed at all?

 

Anonymous Monkey:

Hi, undergrad here

How useful would a Life Sciences degree be for healthcare/life sciences/biopharma IB? Someone can learn the industry without spending too much effort, but learning the raw science, as I see it, can be sort of an unfuckable quality. Is my view flawed at all?


Your view is mostly right. The science background helps you understand pipelines, clinical data, and drug mechanisms faster than peers coming from pure finance. It's harder to fake and gives you credibility with clients.
That said, you still need strong finance fundamentals. The science gets you in the door and makes you better at the job, but you need to know how to model and execute deals. Best combo is life sciences degree plus solid finance coursework or internship. Note, each shop may have a different view on this as some places swing more to one side.
Feel free to DM if you want to discuss further.

https://pharmacoach.carrd.co/
 

Molestiae mollitia dignissimos iste sint et. Omnis facere culpa consequatur rerum et quisquam quia numquam. Soluta et praesentium aut ducimus accusamus.

Dolorem id consequuntur harum quaerat repellendus odio tempora illo. Accusamus a voluptate perspiciatis quo iste perspiciatis. Qui recusandae aliquam et.

Fuga neque vero rerum blanditiis natus tempora magnam. Enim vero tempora eum et quia. A atque non et vel ratione id.

Beatae doloremque itaque cupiditate et iusto et veritatis. Ut non et fugiat reiciendis non. Minus voluptatem iste fugiat est. Maxime odio adipisci ipsa reiciendis cumque dolor. Aperiam ea nihil praesentium vel qui vel. Sunt vel ut in similique est assumenda.

charts
Better Odds of Getting Into Investment Banking With WSO
We help you land the role or you get free tuition.

Career Advancement Opportunities

August 2026 Investment Banking

  • Evercore 01 99.4%
  • Moelis & Company 01 98.9%
  • JPMorgan 01 98.3%
  • Morgan Stanley 08 97.8%
  • Goldman Sachs 02 97.2%

Overall Employee Satisfaction

August 2026 Investment Banking

  • Moelis & Company No 99.4%
  • Evercore No 98.9%
  • Morgan Stanley 01 98.3%
  • Banco Santander 02 97.8%
  • BMO Capital Markets 12 97.2%

Professional Growth Opportunities

August 2026 Investment Banking

  • Evercore 01 99.4%
  • Moelis & Company 01 98.9%
  • Morgan Stanley 06 98.3%
  • Goldman Sachs 01 97.8%
  • JPMorgan 01 97.2%

Total Avg Compensation

August 2026 Investment Banking

  • Vice President (16) $429
  • Associates (47) $258
  • 3rd+ Year Analyst (8) $210
  • 2nd Year Analyst (25) $178
  • Intern/Summer Associate (14) $159
  • 1st Year Analyst (83) $151
  • Intern/Summer Analyst (74) $101
notes
16 IB Interviews Notes

“... there’s no excuse to not take advantage of the resources out there available to you. Best value for your $ are the...”

Leaderboard

1
redever's picture
redever
99.2
2
kanon's picture
kanon
99.0
3
BankonBanking's picture
BankonBanking
99.0
4
Secyh62's picture
Secyh62
99.0
5
dosk17's picture
dosk17
98.9
6
CompBanker's picture
CompBanker
98.9
7
GameTheory's picture
GameTheory
98.9
8
DrApeman's picture
DrApeman
98.9
9
Betsy Massar's picture
Betsy Massar
98.9
10
Jamoldo's picture
Jamoldo
98.8
success
From 10 rejections to 1 dream investment banking internship

“... I believe it was the single biggest reason why I ended up with an offer...”